Health Care: Drugs

Impax Laboratories Inc (IPXL: NASDAQ)

$13.4 n/a | n/a%
12/09/16 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 13.40
52 Week High 44.86
52 Week Low 12.28
Avg. Daily Vol. (Mil) 1.20
Beta (3 year) 1.23
Share Related Items
Mkt Cap (Mil) 989.98
Shares Out (Mil) 73.88
Float (Mil) 64.90
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.40
Current Ratio 2.10
LT Debt/ Equity 0.90
Total Debt / Equity 0.92
Valuation Ratios
Price Earnings n.a.
Price/Sales 1.09
Price/Book 1.10
Price/Cash Flow -10.10
Per Share Data
Earnings -2.54
Sales 12.29
Book Value 12.23
Cash Flow -1.32
Business Summary
Impax Laboratories Inc is a technology-based, specialty pharmaceutical company. It is engaged in the development and commercialization of bioequivalent and brand-name pharmaceuticals, utilizing its controlled-release and other in-house development.
General Information
30831 Huntwood Avenue
Hayward, CA 94544
www.impaxlabs.com
Industry : Drugs
Sector: Health Care
Employees: 1290
CEO: G. Frederick Wilkinson
Short Interest
Current Month (Mil) 2.73
Previous Month (Mil) 3.50
Short Interest Ratio (Days) 1.50
Management Effectiveness
Return on Equity n.a.
Return on Assets -8.50
Return on Investments -10.50
Profitability
Gross Margin 22.90
EBIT Margin -28.20
Profit Margin -19.90

Portfolios with IPXL

Latest IPXL Headlines from TheStreet

More Financial News for IPXL

Press Releases for IPXL

See All Press Releases

Partner Headlines for IPXL

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter